Abstract

Exposure to xenobiotics could favor the transition of nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis in obese patients. Recently, we showed in different models of NAFL that benzo[a]pyrene (B[a]P) and ethanol coexposure induced a steatohepatitis-like state. One model was HepaRG cells incubated with stearate and oleate for 2 weeks. In the present study, we wished to determine in this model whether mitochondrial dysfunction and reactive oxygen species (ROS) overproduction could be involved in the occurrence of this steatohepatitis-like state. CRISPR/Cas9-modified cells were also used to specify the role of aryl hydrocarbon receptor (AhR), which is potently activated by B[a]P. Thus, nonsteatotic and steatotic HepaRG cells were treated with B[a]P, ethanol, or both molecules for 2 weeks. B[a]P/ethanol coexposure reduced mitochondrial respiratory chain activity, mitochondrial respiration, and mitochondrial DNA levels and induced ROS overproduction in steatotic HepaRG cells. These deleterious effects were less marked or absent in steatotic cells treated with B[a]P alone or ethanol alone and in nonsteatotic cells treated with B[a]P/ethanol. Our study also disclosed that B[a]P/ethanol-induced impairment of mitochondrial respiration was dependent on AhR activation. Hence, mitochondrial dysfunction and ROS generation could explain the occurrence of a steatohepatitis-like state in steatotic HepaRG cells exposed to B[a]P and ethanol.

Highlights

  • Nonalcoholic fatty liver disease (NAFLD) refers to the large spectrum of hepatic lesions linked to obesity including nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), and cirrhosis

  • We showed in three different models of NAFL that B[a]P and ethanol coexposure induced the appearance of a steatohepatitis-like state characterized by hepatocyte demise and increased expression of several inflammation markers such as interleukin 1β (IL1β), IL6, tumor necrosis factor α (TNFα), and C-reactive protein (CRP) [14]

  • We looked at the mRNA expression of apolipoprotein A4 (APOA4) and perilipin 1 (PLIN1) because these lipid-related genes are consistently overexpressed whenever steatosis occurs, including in the context of NAFLD [18, 30, 31]

Read more

Summary

Introduction

Nonalcoholic fatty liver disease (NAFLD) refers to the large spectrum of hepatic lesions linked to obesity including nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), and cirrhosis. Most obese individuals present NAFL ( referred to as hepatic steatosis), which is characterized by the accumulation of triglycerides as large cytoplasmic vacuoles. NAFL is benign in the short term, it can progress in the long term to NASH in up to one third of patients [1, 2]. NASH is characterized by fat accumulation and by necroinflammation, fibrosis, and the presence of apoptotic hepatocytes [1, 3]. Several genetic polymorphisms could explain, at least in part, why NAFL progresses to NASH in some obese patients [4, 5]. Nongenetic factors might play a role such as exposure to different types of xenobiotics including drugs, alcohol, and environmental contaminants [6,7,8,9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call